Terns Pharmaceuticals Inc...

NASDAQ: TERN · Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.05
-0.21%
After-hours: Aug 15, 2025, 04:10 PM EDT

Terns Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-88.85M -90.21M -60.34M -50.16M
Depreciation & Amortization
896K 881K 1.03M 512K
Stock-Based Compensation
15.63M 25.54M 10.77M 8.15M
Other Working Capital
4.75M 142K -315K -3.15M
Other Non-Cash Items
-2.09M -5.03M 81K 879K
Deferred Income Tax
23K 141K 392K 219K
Change in Working Capital
4.38M 1.29M -1.04M -1.43M
Operating Cash Flow
-70.02M -67.39M -49.11M -41.83M
Capital Expenditures
-42K -52K -275K -340K
Cash Acquisitions
n/a n/a 22K 119.36K
Purchase of Investments
-169.94M -275.78M -139.73M -166.3M
Sales Maturities Of Investments
157.57M 237.85M 117.73M 46.94M
Other Investing Acitivies
n/a n/a -22K -119.36K
Investing Cash Flow
-12.41M -37.99M -22.27M -119.7M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.68M 340K -158K -1.97M
Financial Cash Flow
164M 41.95M 167.5M 134.39M
Net Cash Flow
81.51M -63.31M 95.54M -27.16M
Free Cash Flow
-70.06M -67.44M -49.38M -42.17M